IP Library Granted Patent US 11,944,703
Granted Patent B2
US 11,944,703 · App. 18/365,024 · Granted Apr 2, 2024

Ocular injector and methods for accessing suprachoroidal space of the eye

Inventors: Ronald Yamamoto (San Francisco, CA); Stanley R. Conston (San Carlos, CA); David Sierra (Aptos, CA)
Assignee: Clearside Biomedical, Inc.
A61K9/0048A61F9/0017A61F9/0026A61F9/007A61F9/00736A61K9/0051A61K9/1635A61K31/717A61K31/718A61K31/722A61K31/728A61K31/737A61K47/36A61M5/486A61K9/14A61M2005/3103A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,944,703
App. No.
18/365,024
Granted
Apr 2, 2024
Kind
B2
Abstract

An ocular medical injector is provided for drug delivery. A method includes inserting a puncture member of the medical injector into the eye until the puncture member reaches the suprachoroidal space (SCS). The puncture member defines a lumen therethrough. With the puncture member disposed within the SCS, a flexible cannula is advanced distally through the lumen of the puncture member, beyond the distal end portion of the puncture member and along the SCS towards a posterior region of the eye. The flexible cannula has an atraumatic distal tip and defines a lumen therethrough. With the distal tip of the flexible cannula disposed within the SCS beyond a distal end portion of the puncture member, a therapeutic substance is administered to the SCS.

Claims (35)

1. A method, comprising:

advancing a distal end portion of a puncture member of a medical injector through a sclera of an eye until the distal end portion of the puncture member reaches a suprachoroidal space (SCS), the puncture member defining a lumen having a longitudinal axis;

moving a flexible cannula distally relative to the puncture member such that an atraumatic distal end of the flexible cannula exits the lumen along the longitudinal axis, and beyond the distal end portion of the puncture member along the SCS, thereby expanding the SCS; and

administering a drug formulation to the expanded SCS.

2. The method of claim 1 , further comprising:

during the moving, illuminating the SCS via the flexible cannula to verify disposal of the flexible cannula in the SCS.

3. The method of claim 1 , wherein prior to the moving, the atraumatic distal end of the flexible cannula is disposed in the lumen of the puncture member proximal to the distal end portion of the puncture member.

4. The method of claim 1 , wherein the flexible cannula includes a lubricious coating to aid in advancement of the flexible cannula.

5. The method of claim 1 , wherein the puncture member is a needle having a gauge between about 20 to about 25.

6. The method of claim 1 , wherein the distal end portion of the puncture member is in-line with a proximal end portion of the puncture member.

7. The method of claim 1 , wherein the flexible cannula provides an inward distending action to the choroid upon contacting the choroid to prevent trauma to a choroid.

8. The method of claim 1 , further comprising:

guiding placement of the distal end portion of the puncture member via a sensor.

9. The method of claim 8 , wherein the sensor includes at least one of a light pipe or an ultrasound sensor.

10. A method of administering a therapeutic substance to an eye via an ocular injector, the ocular injector including a puncture member defining a lumen with a longitudinal axis and a flexible cannula movably disposed in the lumen, the flexible cannula having an atraumatic distal tip, the method comprising:

inserting a distal end portion of the puncture member into the eye until the distal end portion of the puncture member reaches a suprachoroidal space (SCS);

advancing the flexible cannula distally through the lumen of the puncture member such that the atraumatic distal tip of the flexible cannula exits the lumen along the longitudinal axis, thereby expanding the SCS; and

administering the therapeutic substance to the expanded SCS such that the therapeutic substance is advanced posteriorly in the SCS.

11. The method of claim 10 , further comprising:

during the advancing, illuminating the SCS via the flexible cannula to verify disposal of the flexible cannula in the SCS.

12. The method of claim 10 , wherein the flexible cannula includes a lubricious coating to aid in advancement of the flexible cannula.

13. The method of claim 10 , wherein the puncture member is a needle having a gauge between about 20 to about 25.

14. The method of claim 10 , wherein the distal end portion of the puncture member is in-line with a proximal end portion of the puncture member.

15. The method of claim 10 , wherein the flexible cannula provides an inward distending action to the choroid upon contacting the choroid to prevent trauma to a choroid.

16. A method of administering a drug formulation to an eye via an ocular injector, the ocular injector including a puncture member defining a lumen with a longitudinal axis and a flexible cannula movably disposed in the lumen, the flexible cannula having an atraumatic distal tip, the method comprising:

inserting a distal end portion of the puncture member into the eye until the distal end portion of the puncture member reaches a suprachoroidal space (SCS);

advancing the flexible cannula distally through the lumen of the puncture member such that the atraumatic distal tip of the flexible cannula exits the lumen along the longitudinal axis, thereby expanding the SCS; and

administering the drug formulation to the expanded SCS such that the drug formulation is advanced posteriorly in the SCS.

17. The method of claim 16 , further comprising:

during the advancing, illuminating the SCS via the flexible cannula to verify disposal of the flexible cannula in the SCS.

18. The method of claim 16 , wherein the flexible cannula includes a lubricious coating to aid in advancement of the flexible cannula.

19. The method of claim 16 , wherein the puncture member is a needle having a gauge between about 20 to about 25.

20. The method of claim 16 , wherein the distal end portion of the puncture member is in-line with a proximal end portion of the puncture member.

21. The method of claim 16 , wherein the flexible cannula provides an inward distending action to the choroid upon contacting the choroid to prevent trauma to a choroid.

22. The method of claim 16 , wherein the flexible cannula includes a microcatheter.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2023
From: YAMAMOTO, RONALD; CONSTON, STANLEY R.; SIERRA, DAVID
To: ISCIENCE INTERVENTIONAL CORPORATION
Reel/Frame 065586/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2023
From: ISCI HOLDINGS INC.
To: CLEARSIDE BIOMEDICAL, INC.
Reel/Frame 065587/0136 →
CHANGE OF NAME Recorded Nov 16, 2023
From: ISCIENCE INTERVENTIONAL CORPORATION
To: ISCI HOLDINGS INC.
Reel/Frame 065608/0942 →
Continuity (6)
Continuation 17711495 · Apr 1, 2022
Continuation 17217455 · Mar 30, 2021
Continuation 16741473 · Jan 13, 2020
Continuation 11709941 · Feb 21, 2007
Provisional Application 60776903 · Feb 22, 2006
Related Publication 20230372235A1 · Nov 23, 2023
Cited By (1)
US 12,201,558